Our study focused on those receiving routine clinical care and did not show the improvement of HbA1c associated with persistent C‐peptide in DCCT, with the benefit of maintained endogenous insulin secretion limited to lower insulin dose and less hypoglycaemia. Here, INS is linked to Hypoglycemia.